IP Library Patent Application 12249880
Patent Application
App. No. 12/249,880

METHOD FOR PREPARING LYSOBACTIN DERIVATIVES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/249,880
Abstract

Method for preparing cyclic depsipeptides having the following formula (I) by intramolecular cyclization.

Claims (75)

1 . A method for preparing cyclic depsipeptides of the following formula (I)

in which R 1 is H or CH 3 ,

in which R 2 is hydrogen, C 3 -C 6 -cycloalkyl, C 5 -C 6 -cycloalkenyl, C 3 -C 6 cycloalkylmethyl, 5- to 7-membered heterocyclylmethyl, methyl, ethyl, n-propyl, isopropyl, 1-methylprop-1-yl, 2-methylprop-1-yl, 2,2-dimethylprop-1-yl, 1,1-dimethylprop-1-yl, 1-ethylprop-1-yl, 1-ethyl-1-methylprop-1-yl, n-butyl, 2-methylbut-1-yl, 3-methylbut-1-yl, 1-ethylbut-1-yl, tert-butyl, 4-methylpent-1-yl, n-hexyl, alkenyl or aryl,

whereby R 2 may be substituted with 0, 1, 2 or 3 substituents selected independently of one another from the group consisting of halogen, hydroxy, amino, cyano, trimethylsilyl, alkyl, alkoxy, benzyloxy, C 3 -C 6 -cycloalkyl, aryl, 5- to 10-membered heteroaryl, alkylamino, arylamino, alkylcarbonylamino, arylcarbonylamino, alkylcarbonyl, alkoxycarbonyl, arylcarbonyl and benzyloxycarbonylamino,

wherein aryl and heteroaryl in turn may be substituted with 0, 1, 2 or 3 substituents selected independently of one another from the group consisting of halogen, hydroxy, amino, cyano, nitro, alkyl, alkoxy and phenyl,

in which R 3 is hydrogen or C 1 -C 4 -alkyl,

or

in which R 2 and R 3 together with the carbon atom to which they are bonded form a C 3 -C 6 -cycloalkyl ring or a 5- to 7-membered heterocyclyl ring, whereby the cycloalkyl ring and the heterocyclyl ring may be substituted with 0, 1, 2 or 3 substituents selected independently of one another from the group consisting of trifluoromethyl, alkyl, alkoxy and alkylcarbonyl,

in which R 4 is alkyl, C 3 -C 6 -cycloalkyl, 5- to 7-membered heterocyclyl, aryl, 5- or 6-membered heteroaryl, alkylcarbonyl, alkoxycarbonyl, C 3 -C 6 -cycloalkylcarbonyl, 5- to 7-membered heterocyclylcarbonyl, arylcarbonyl, 5- or 6-membered heteroarylcarbonyl or alkylaminocarbonyl,

whereby alkyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxycarbonyl, cycloalkylcarbonyl, heterocyclylcarbonyl, arylcarbonyl, heteroarylcarbonyl and alkylaminocarbonyl may be substituted with 0, 1, 2 or 3 substituents selected independently of one another from the group consisting of halogen, hydroxy, amino, alkylamino and phenyl,

and

whereby alkylcarbonyl is substituted with an amino or alkylamino substituent,

and

whereby alkylcarbonyl may be substituted with a further 0, 1 or 2 substituents selected independently of one another from the group consisting of halogen, hydroxy, trimethylsilyl, alkoxy, alkylthio, benzyloxy, C 3 -C 6 -cycloalkyl, phenyl, naphthyl, 5- to 10-membered heteroaryl, alkylcarbonylamino, alkoxycarbonylamino, arylcarbonylamino, arylcarbonyloxy, benzyloxycarbonyl and benzyloxycarbonylamino,

whereby phenyl and heteroaryl in turn may be substituted with 0, 1, 2 or 3 substituents selected independently of one another from the group consisting of halogen, hydroxy, nitro, alkyl, alkoxy and phenyl,

or two substituents on the same carbon atom in the alkylcarbonyl together with the carbon atom to which they are bonded form a C 3 -C 6 -cycloalkyl ring or a 5- to 7-membered heterocyclyl ring,

whereby the cycloalkyl ring and the heterocyclyl ring may be substituted with 0, 1, 2 or 3 substituents selected independently of one another from the group consisting of trifluoromethyl, alkyl and alkoxy,

or

whereby the cycloalkyl ring may be benzo-fused,

in which R 5 is hydrogen, C 1 -C 4 -alkyl, cyclopropyl or cyclopropylmethyl,

or

in which R 4 and R 5 together with the nitrogen atom to which they are bonded form a 5- to 7-membered heterocyclyl ring, whereby the heterocyclyl ring may be substituted with 0, 1, 2, or 3 substituents selected independently of one another from the group consisting of halogen, hydroxy, amino, cyano, alkyl, alkoxy and alkylamino,

by intramolecular cyclization of a compound of the following formula (II)

in which R 1 to R 5 are as defined above,

in which X is OH, an active ester, a pseudohalogen or a halogen, and

in which PG is H or a suitable protecting group,

and subsequent deprotection of the cyclic intermediate to form said cyclic depsipeptide of formula (I).

2 . The method of claim 1 , whereby said compound of formula (II) is a compound of the following formula (IIa)

in which X and R 1 are as defined in claim 1 ,

in which R 6 is isopropylmethyl, tert-butylmethyl, 2,2-dimethylbut-1-yl, 2-ethyl-2-methylbut-1-yl, 2,2-diethylbut-1-yl, 2,2-dimethylpent-1-yl, 3-pyridylmethyl, 4-trifluoromethyl-3-pyridylmethyl, benzyl or trimethylsilylmethyl,

in which R 7 is isopropylmethyl, tert-butylmethyl, 2,2-dimethylbut-1-yl, 2-ethyl-2-methylbut-1-yl, 2,2-diethylbut-1-yl, 2,2-dimethylpent-1-yl, trimethylsilylmethyl or benzyl, and

in which PG is H or a suitable protecting group.

3 . The method of claim 2 , whereby

R 6 is isopropylmethyl, tert-butylmethyl or 3-pyridylmethyl, and

R 7 is isopropylmethyl, tert-butylmethyl or trimethylsilylmethyl.

4 . The method of claim 3 , whereby R 6 ═R 7 and is isopropylmethyl.

5 . The method of claim 1 , whereby X is OH.

6 . The method of claim 1 , whereby R 1 is CH 3 .

7 . The method of claim 1 , further comprising the preparation of said compound of formula (II) by coupling a compound of the following formula (III) with a compound of the following formula (IV)

in which R 1 to R 5 are as defined in claim 1 ,

in which Y is OH, an active ester, a pseudohalogen or a halogen, and

in which PG is H or a suitable protecting group,

and, where appropriate, partial or complete deprotection of the intermediate, as well as where appropriate conversion of the carboxy group of the 3-hydroxyphenylalanine into a group of formula —C(═O)X in which X is as defined in claim 1 .

8 . The method of claim 7 , whereby said compound of formula (III) is a compound of the following formula (IIIa)

in which R 6 and R 7 are as defined in claim 2 , and

in which PG is H or a suitable protecting group.

9 . The method of claim 7 , further comprising the preparation of said compound of formula (III) by coupling a compound of the following formula (V) with a compound of the following formula (VI)

in which R 2 to R 5 are as defined in claim 1 ,

in which Z is OH, an active ester, a pseudohalogen or a halogen, and

in which PG is H or a suitable protecting group,

and, where appropriate, partial or complete deprotection of the intermediate.

10 . The method of claim 9 , whereby said compound of formula (V) is a compound of the following formula (Va)

in which R 6 and R 7 are as defined in claim 2 , and

in which PG is H or a suitable protecting group.

11 . A compound of the following formula (III)

in which R 2 to R 5 are as defined in claim 1 , and

in which PG is H or a suitable protecting group.

12 . The compound of claim 11 , having the following formula (IIIa)

in which R 6 and R 7 are as defined in claim 2 , and

in which PG is H or a suitable protective group.

13 . The compound of claim 12 , having the following formula (IIIb)

14 . A method for preparing a compound of claim 11 , comprising the coupling of a compound of formula (V) with a compound of formula (VI)

in which R 2 to R 5 are as defined in claim 1 ,

in which Z is OH, an active ester, a pseudohalogen or a halogen, and

in which PG is H or a suitable protecting group,

and, where appropriate, partial or complete deprotection of the intermediate.

15 . A compound of the following formula (VI)

in which Z is OH, an active ester, a pseudohalogen or a halogen, and

in which PG is H or a suitable protecting group.

16 . The compound of claim 15 , having the following formula (VIa)

17 . A method for preparing a compound of claim 15 , comprising the coupling of a compound of the following formula (VII) with a compound of the following formula (VIII)

in which PG is H or a suitable protecting group,

and, where appropriate, complete or partial deprotection of the intermediate.

18 . The method of claim 17 , whereby said compound of formula (VII) is a compound of the following formula (VIIa).

19 . The method of claim 17 , whereby said compound of formula (VIII) is a compound of the following formula (VIIIa).

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2009
From: VON NUSSBAUM, FRANZ; ANLAUF, SONJA; KOEBBERLING, JOHANNES; TELSER, JOACHIM; HAEBICH, DIETER
To: BAYER HEALTHCARE AG
Reel/Frame 022784/0370 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2009
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: AICURIS GMBH & CO. KG
Reel/Frame 022784/0606 →
MERGER Recorded Jun 4, 2009
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 022802/0371 →